Does lung ultrasound help in determining the need of surfactant administration?

Abstract

Background. Fetal lung immaturity can lead to neonatal respiratory distress syndrome (RDS), a significant cause of respiratory failure and neonatal mortality in premature infants due to lack of pulmonary surfactant. Lung ultrasound may aid in deciding when to administer surfactant. Case report. The patient was diagnosed with respiratory distress syndrome (RDS) and received timely surfactant therapy based on their FiO2 and Lung Ultrasound Score. This led to an improved clinical status and successful extubation within 48 hours. After being discharged at 30 days, the patient showed normal development during a 7-month follow-up period. Conclusions. A favorable outcome results from prompt and targeted lung ultrasound (LUS) interventions, specifically highlighting the efficacy of timely surfactant intervention and collaborative healthcare management in addressing RDS in neonates.